Literature DB >> 22438343

Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia.

Gregory J Moran1, Anusha Krishnadasan, Rachel J Gorwitz, Greg E Fosheim, Valerie Albrecht, Brandi Limbago, David A Talan.   

Abstract

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of skin infections. Recent case series describe severe community-acquired pneumonia (CAP) caused by MRSA, but the prevalence and risk factors are unknown.
METHODS: We prospectively enrolled adults hospitalized with CAP from 12 university-affiliated emergency departments during the winter-spring of 2006 and 2007. Clinical information and culture results were collected, and factors associated with MRSA were assessed.
RESULTS: Of 627 patients, 595 (95%) had respiratory (50%) and/or blood cultures (92%) performed. A pathogen was identified in 102 (17%); MRSA was identified in 14 (2.4%; range by site, 0%-5%) patients and in 5% of patients admitted to the intensive care unit. Two (14%) MRSA pneumonia patients died. All 9 MRSA isolates tested were pulsed-field type USA300. Features significantly associated with isolation of MRSA (as compared with any other or no pathogen) included patient history of MRSA; nursing home admission in the previous year; close contact in the previous month with someone with a skin infection; multiple infiltrates or cavities on chest radiograph; and comatose state, intubation, receipt of pressors, or death in the emergency department.
CONCLUSIONS: Methicillin-resistant Staphylococcus aureus remains an uncommon cause of CAP. Detection of MRSA was associated with more severe clinical presentation.

Entities:  

Mesh:

Year:  2012        PMID: 22438343     DOI: 10.1093/cid/cis022

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

1.  Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia.

Authors:  Benjamin Dangerfield; Andrew Chung; Brandon Webb; Maria Teresa Seville
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

Review 2.  Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.

Authors:  James E Frampton
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

3.  Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia.

Authors:  Wesley H Self; Richard G Wunderink; Derek J Williams; Tyler W Barrett; Adrienne H Baughman; Carlos G Grijalva
Journal:  Acad Emerg Med       Date:  2015-05-20       Impact factor: 3.451

4.  Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus.

Authors:  Feifei Xia; Xin Li; Bin Wang; Pengjuan Gong; Feng Xiao; Mei Yang; Lei Zhang; Jun Song; Liyuan Hu; Mengjun Cheng; Changjiang Sun; Xin Feng; Liancheng Lei; Songying Ouyang; Zhi-Jie Liu; Xinwei Li; Jingmin Gu; Wenyu Han
Journal:  Appl Environ Microbiol       Date:  2015-10-16       Impact factor: 4.792

5.  Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.

Authors:  Nidhu Baby; Andrew C Faust; Terri Smith; Lyndsay A Sheperd; Laura Knoll; Edward L Goodman
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.

Authors:  Joseph R Paonessa; Raj D Shah; Chiagozie I Pickens; Bryan D Lizza; Helen K Donnelly; Michael Malczynski; Chao Qi; Richard G Wunderink
Journal:  Chest       Date:  2019-02-15       Impact factor: 9.410

7.  Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia.

Authors:  Sarah Dunaway; Kara W Orwig; Zachary Q Arbogast; Zachary L Myers; James A Sizemore; Stephanie E Giancola
Journal:  Int J Clin Pharm       Date:  2018-05-02

Review 8.  Methicillin-resistant Staphylococcus aureus as a cause of invasive infections in Central Africa: a case report and review of the literature.

Authors:  M A M Huson; R Kalkman; J Remppis; J O Beyeme; C Kraef; F Schaumburg; A S Alabi; M P Grobusch
Journal:  Infection       Date:  2014-01-25       Impact factor: 3.553

9.  Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.

Authors:  Nicole Le Saux; Joan L Robinson
Journal:  Paediatr Child Health       Date:  2015 Nov-Dec       Impact factor: 2.253

10.  Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010.

Authors:  Barbara E Jones; Makoto M Jones; Benedikt Huttner; Gregory Stoddard; Kevin Antoine Brown; Vanessa W Stevens; Tom Greene; Brian Sauer; Karl Madaras-Kelly; Michael Rubin; Matthew Bidwell Goetz; Matthew Samore
Journal:  Clin Infect Dis       Date:  2015-07-29       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.